Table 4.

The associations between phthalates and liver fibrosis in US adults.

Phthalate	Fibrosis (LSM ≥8 Kpa)		Ln LSM
metabolites
	OR (95%CI)	P FDR	β (95%CI)	P FDR
MECPP
Q1	Ref.		Ref.
Q2	1.316 (0.304, 5.692)	0.695	−0.006 (−0.115, 0.103)	0.903
Q3	3.284 (0.995, 10.841)	0.153	0.072 (−0.054, 0.197)	0.531
Q4	0.697 (0.220, 2.214)	0.695	−0.033 (−0.106, 0.04)	0.531
MEOHP
Q1	Ref.		Ref.
Q2	0.971 (0.442, 2.131)	0.938	−0.025 (−0.105, 0.054)	0.760
Q3	1.130 (0.390, 3.273)	0.938	0.001 (−0.112, 0.114)	0.981
Q4	0.536 (0.129, 2.218)	0.938	−0.068 (−0.145, 0.008)	0.228
MEHHP
Q1	Ref.		Ref.
Q2	1.679 (0.592, 4.758)	0.458	0.006 (−0.071, 0.084)	0.864
Q3	1.660 (0.670, 4.115)	0.458	−0.032 (−0.128, 0.064)	0.864
Q4	0.595 (0.110, 3.207)	0.521	−0.028 (−0.151, 0.095)	0.864
MCiNP
Q1	Ref.		Ref.
Q2	0.784 (0.262, 2.350)	0.645	0.048 (−0.045, 0.141)	0.429
Q3	1.871 (0.576, 6.074)	0.411	0.109 (0.042, 0.176)	0.009
Q4	1.654 (0.700, 3.905)	0.411	0.042 (−0.081, 0.165)	0.476
MCiOP
Q1	Ref.		Ref.
Q2	0.602 (0.149, 2.418)	0.673	0.046 (−0.065, 0.157)	0.392
Q3	1.987 (0.764, 5.167)	0.438	0.11 (0.046, 0.174)	0.006
Q4	0.949 (0.254, 3.541)	0.935	0.036 (−0.05, 0.122)	0.392
MOiNP
Q1	Ref.		Ref.
Q2	2.861 (0.587, 13.93)	0.265	0.099 (0.005, 0.193)	0.123
Q3	3.611 (0.793, 16.42)	0.265	0.067 (−0.036, 0.17)	0.277
Q4	1.589 (0.588, 4.291)	0.336	0.047 (−0.058, 0.151)	0.357